Nanjing, China · Founded 2019 · Privately Held (backing)
Manufacturer of mRNA vaccine drugs designed to treat infectious diseases and cancers. TheraRNA is based in Nanjing, China and was founded in 2019. Its last reported valuation was $27.9 million in Dec 2022. It has raised $6.4 million.
Last reported valuation
$27.9M
Oct 2026
Priced at
—
Total raised
$6.4M
Last round
—
Team — not yet on record
No current team members for TheraRNA are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TheraRNA with a free account
·Watch TheraRNA: the Monday email on marks, rounds and moves
